Clinical assessment of acute heart failure syndromes: Emergency department through the early post-discharge period

Heart

Volumn 97, Issue 19, 2011, Pages 1607-1618

  Harinstein, Matthew E ^a   Flaherty, James D ^b   Fonarow, Gregg C ^c   Mehra, Mandeep R ^d   Lang, Roberto M ^e   Kim, Raymond J ^f   Cleland, John G ^g   Knight, Bradley P ^b   Pang, Peter S ^b   Bonow, Robert O ^b   Gheorghiade, Mihai ^b,f  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART FAILURE; ANAMNESIS; ANGIOCARDIOGRAPHY; CARDIOVERSION; CLINICAL ASSESSMENT; COMORBIDITY; CORONARY ARTERY DISEASE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERGENCY WARD; HEALTH CARE MANAGEMENT; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; LUNG CONGESTION; MITRAL VALVE REGURGITATION; NONISCHEMIC CARDIOMYOPATHY; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY;

ACUTE DISEASE; CARDIOLOGY SERVICE, HOSPITAL; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HEMODYNAMICS; HUMANS; PATIENT DISCHARGE; PHYSICAL EXAMINATION; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SYNDROME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 80052678775     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2011.222331     Document Type: Review

References (24)

1. Fonarow GC, Stough WG, Abraham WT, et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007;50:768-77. (Pubitemid 47243795)
2. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442. The European guidelines on the diagnosis and treatment of patients presenting with AHSF.
3. Peacock WF, Braunwald E, Abraham W, et al. National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. J Am Coll Cardiol 2010;56:343-51. Recommendations from an expert panel of a range of medical professionals regarding the emergency department assessment of patients presenting with AHSF and the need for further research.
4. Pang PS, Cleland JG, Teerlink JR, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 2008;29:816-24. A proposal for the Provocative Dyspnea Assessment, which is a method of measurement using a five point Likert scale that yields a final Dyspnea Severity Score to grade a patient's degree of dyspnoea. (Pubitemid 351431028)
5. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. (Pubitemid 34764819)
6. Fonarow GC, Peacock WF, Horwich TB, et al. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 2008;101:231-7.
7. Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8. Registry data describing the predictive value of hyponatraemia in patients hospitalised with heart failure. (Pubitemid 47343897)
8. Filippatos G, Rossi J, Lloyd-Jones DM, et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail 2007;13:360-4. (Pubitemid 46977793)
9. Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 2010;12:423-33. An excellent review on the available methods for evaluating congestion and a proposal for a method to quantify a patient's degree of congestion.
10. Chaudhry SI, Wang Y, Concato J, et al. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007;116:1549-54. (Pubitemid 47511418)
11. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-8. (Pubitemid 41170070)
12. Flaherty JD, Bax JJ, De Luca L, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol 2009;53:254-63. A nice review on the assessment and management of patients with AHSF and CAD.
13. Beohar N, Erdogan AK, Lee DC, et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol 2008;52:13-16. (Pubitemid 351852938)
14. Schuijf JD, Shaw LJ, Wijns W, et al. Cardiac imaging in coronary artery disease: differing modalities. Heart 2005;91:1110-17. (Pubitemid 41060032)
15. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-53. (Pubitemid 37296539)
16. Braun J, Van de Veire NR, Klautz RJ, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg 2008;85:430-6; discussion 6-7.
17. Feldman T, Foster E, Glower DG, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
18. Soman P, Lahiri A, Mieres JH, et al. Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging. J Nucl Cardiol 2009;16:82-91.
19. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53. One of the first articles to describe the utility of contrast enhanced MRI for the detection of myocardial viability.
20. Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-25.
21. Seghatol FF, Shah DJ, Diluzio S, et al. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:854-9. (Pubitemid 38429596)
22. Bonow RO. Identification of viable myocardium. Circulation 1996;94:2674-80. (Pubitemid 26411724)
23. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010;303:1716-22.
24. Metra M, Gheorghiade M, Bonow RO, et al. Postdischarge assessment after a heart failure hospitalization: the next step forward. Circulation 2010;122:1782-85.